TABLE 6. Reported cases of notifiable diseases and rates per 100,000, by race, excluding U.S. territories - - United States, 2016

column labels in same order that data fields appears in each record below:
Disease
American Indian or</br>Alaska Native, No.
American Indian or</br>Alaska Native, Rate
Asian or Pacific</br>Islander, No.
Asian or Pacific</br>Islander, Rate
Black, No.
Black, Rate
White, No.
White, Rate
Other Race, No.
Race not stated, No.
Suppressed *, No.
Total

tab delimited data:
Anthrax 	—	—	—	—	—	—	—	—	—	—	—	—
Arboviral diseases, Chikungunya virus disease 	—	—	65	0.32	14	0.03	79	0.03	18	71	—	247
Arboviral diseases, Eastern equine encephalitis virus disease, Neuroinvasive 	S	S	S	S	S	S	S	S	S	S	7	7
Arboviral diseases, Eastern equine encephalitis virus disease, Non-neuroinvasive 	—	—	—	—	—	—	—	—	—	—	—	—
Arboviral diseases, Jamestown Canyon  virus disease, Neuroinvasive 	S	S	S	S	S	S	S	S	S	S	7	7
Arboviral diseases, Jamestown Canyon  virus disease, Non-neuroinvasive 	S	S	S	S	S	S	S	S	S	S	8	8
Arboviral diseases, La Crosse  virus disease, Neuroinvasive 	—	—	—	—	—	—	25	0.01	—	6	—	31
Arboviral diseases, La Crosse  virus disease, Non-neuroinvasive 	S	S	S	S	S	S	S	S	S	S	4	4
Arboviral diseases, Powassan virus disease, Neuroinvasive 	S	S	S	S	S	S	S	S	S	S	21	21
Arboviral diseases, Powassan virus disease, Non-neuroinvasive 	S	S	S	S	S	S	S	S	S	S	1	1
Arboviral diseases, St. Louis encephalitis virus disease, Neuroinvasive 	S	S	S	S	S	S	S	S	S	S	7	7
Arboviral diseases, St. Louis encephalitis virus disease, Non-neuroinvasive 	S	S	S	S	S	S	S	S	S	S	1	1
Arboviral diseases, West Nile virus disease, Neuroinvasive 	11	0.24	12	0.06	63	0.14	920	0.36	35	267	—	1,308
Arboviral diseases, West Nile virus disease, Non-neuroinvasive 	5	0.11	6	0.03	21	0.05	600	0.24	11	198	—	841
Arboviral diseases, Western equine encephalitis virus disease, Neuroinvasive 	—	—	—	—	—	—	—	—	—	—	—	—
Arboviral diseases, Western equine encephalitis virus disease, Non-neuroinvasive 	—	—	—	—	—	—	—	—	—	—	—	—
Babesiosis, Total 	7	0.26	44	0.28	41	0.14	1,150	0.63	19	649	—	1,910
Babesiosis, Confirmed 	4	0.15	44	0.28	36	0.12	947	0.52	16	538	—	1,585
Babesiosis, Probable 	3	0.11	—	—	5	0.02	203	0.11	3	111	—	325
Botulism, Total 	5	0.11	9	0.04	19	0.04	123	0.05	3	42	—	201
Botulism, Foodborne 	3	0.06	2	0.01	12	0.03	9	0.00	—	5	—	31
Botulism, Infant 	1	1.29	7	2.80	5	0.73	96	3.24	3	32	—	144
Botulism, Other (wound & unspecified) 	1	0.02	—	—	2	0.00	18	0.01	—	5	—	26
Brucellosis 	2	0.04	4	0.02	3	0.01	85	0.03	15	18	—	127
Campylobacteriosis 	479	10.35	1,582	7.72	2,721	6.01	36,747	14.54	3,189	15,402	—	60,120
Chancroid †	S	S	S	S	S	S	S	S	S	S	7	7
Chlamydia trachomatis infection †	18,735	404.63	25,594	124.92	452,165	998.00	519,401	205.54	80,410	502,049	—	1,598,354
Cholera 	S	S	S	S	S	S	S	S	S	S	15	15
Coccidioidomycosis §	167	7.03	332	3.45	431	3.02	3,659	3.49	542	6,698	—	11,829
Cryptosporidiosis, Total 	106	2.29	154	0.75	1,283	2.83	9,052	3.58	471	2,387	—	13,453
Cryptosporidiosis, Confirmed 	75	1.62	101	0.49	864	1.91	5,663	2.24	306	1,628	—	8,637
Cryptosporidiosis, Probable 	31	0.67	53	0.26	419	0.92	3,389	1.34	165	759	—	4,816
Cyclosporiasis 	1	0.03	14	0.07	14	0.03	370	0.16	28	110	—	537
Dengue virus infections, Dengue ¶	1	0.02	161	0.79	60	0.13	396	0.16	57	228	—	903
Dengue virus infections, Dengue-like illness ¶	—	—	6	0.03	2	0.00	13	0.01	8	11	—	40
Dengue virus infections, Severe dengue ¶	S	S	S	S	S	S	S	S	S	S	10	10
Diphtheria 	—	—	—	—	—	—	—	—	—	—	—	—
Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection 	35	0.85	29	0.15	17	0.04	2,686	1.10	36	1,348	—	4,151
Ehrlichiosis and Anaplasmosis, Ehrlichia chaffeensis infection 	8	0.19	4	0.02	24	0.05	963	0.40	18	360	—	1,377
Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection 	S	S	S	S	S	S	S	S	S	S	22	22
Ehrlichiosis and Anaplasmosis, Undetermined ehrlichiosis/anaplasmosis 	2	0.05	2	0.01	1	0.00	131	0.05	7	57	—	200
Giardiasis 	93	2.60	430	2.45	1,333	3.89	8,049	4.06	728	5,677	—	16,310
Gonorrhea †	6,059	130.86	6,208	30.30	192,977	425.93	144,335	57.12	20,565	98,370	—	468,514
Haemophilus influenzae, invasive disease, All ages, all serotypes 	62	1.34	75	0.37	671	1.48	3,183	1.26	144	760	—	4,895
Haemophilus influenzae, invasive disease, Age <5 years, Serotype b 	5	1.30	—	—	1	0.03	19	0.13	1	4	—	30
Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype 	15	3.89	3	0.23	38	1.11	79	0.53	3	21	—	159
Haemophilus influenzae, invasive disease, Age <5 years, Nontypeable 	4	1.04	4	0.31	36	1.06	111	0.75	9	32	—	196
Haemophilus influenzae, invasive disease, Age <5 years, Unknown serotype 	7	1.81	9	0.70	31	0.91	96	0.65	15	29	—	187
Hansen's disease 	—	—	12	0.06	5	0.01	36	0.02	1	24	—	78
Hantavirus infection, non-hantavirus pulmonary syndrome 	S	S	S	S	S	S	S	S	S	S	6	6
Hantavirus pulmonary syndrome 	8	0.18	—	—	—	—	19	0.01	1	3	—	31
Hemolytic uremic syndrome post-diarrheal 	2	0.04	7	0.04	7	0.02	239	0.10	21	31	—	307
Hepatitis, A, acute **	3	0.06	301	1.47	141	0.31	1,073	0.42	142	347	—	2,007
Hepatitis, B, acute **	15	0.33	56	0.27	389	0.87	2,187	0.87	131	440	—	3,218
Hepatitis, B, perinatal infection **	—	—	18	3.54	4	0.29	1	0.02	1	8	—	32
Hepatitis, C, acute **	71	1.77	25	0.13	135	0.31	2,221	0.93	82	408	—	2,942
Human immunodeficiency virus diagnoses 	219	4.73	801	3.91	15,632	34.50	9,398	3.72	8,725	—	—	34,775
Influenza-associated pediatric mortality 	1	0.07	6	0.13	9	0.07	55	0.10	1	10	—	82
Invasive pneumococcal disease, All ages 	309	10.75	218	1.84	2,821	7.58	10,403	5.51	457	3,418	—	17,626
Invasive pneumococcal disease, All ages, Confirmed 	308	10.71	218	1.84	2,817	7.57	10,388	5.50	457	3,415	—	17,603
Invasive pneumococcal disease, All ages, Probable 	S	S	S	S	S	S	S	S	S	S	23	23
Invasive pneumococcal disease, Age <5 years 	18	0.53	41	0.32	223	0.56	591	0.29	42	227	—	1,142
Invasive pneumococcal disease, Age <5 years, Confirmed 	17	5.85	41	4.93	222	7.42	589	4.98	42	226	—	1,137
Invasive pneumococcal disease, Age <5 years, Probable 	S	S	S	S	S	S	S	S	S	S	5	5
Legionellosis 	26	0.56	99	0.48	1,068	2.36	3,891	1.54	242	815	—	6,141
Leptospirosis 	—	—	8	0.05	1	0.00	38	0.02	13	18	—	78
Listeriosis 	9	0.19	70	0.34	68	0.15	533	0.21	20	86	—	786
Lyme disease, Total 	81	1.75	303	1.55	298	0.66	18,841	7.47	990	15,916	—	36,429
Lyme disease, Confirmed 	57	1.23	210	1.07	205	0.45	13,381	5.30	776	11,574	—	26,203
Lyme disease, Probable 	24	0.52	93	0.48	93	0.21	5,460	2.16	214	4,342	—	10,226
Malaria 	6	0.13	91	0.44	1,052	2.32	248	0.10	67	491	—	1,955
Measles, Total 	—	—	8	0.04	5	0.01	37	0.01	1	34	—	85
Measles, Indigenous 	—	—	2	0.01	2	0.00	32	0.01	—	32	—	68
Measles, Imported 	S	S	S	S	S	S	S	S	S	S	17	17
Meningococcal disease, All serogroups 	9	0.19	12	0.06	60	0.13	229	0.09	15	50	—	375
Meningococcal disease, Serogroups ACWY 	7	0.15	4	0.02	22	0.05	70	0.03	6	17	—	126
Meningococcal disease, Serogroup B 	1	0.02	1	0.00	15	0.03	58	0.02	2	9	—	86
Meningococcal disease, Other serogroups 	S	S	S	S	S	S	S	S	S	S	21	21
Meningococcal disease, Unknown serogroup 	1	0.02	6	0.03	19	0.04	90	0.04	6	20	—	142
Mumps 	20	0.43	2,140	10.45	220	0.49	2,980	1.18	135	874	—	6,369
Novel Influenza A virus infections 	S	S	S	S	S	S	S	S	S	S	23	23
Pertussis 	123	2.66	312	1.52	775	1.71	11,694	4.63	649	4,419	—	17,972
Plague 	S	S	S	S	S	S	S	S	S	S	4	4
Poliomyelitis, paralytic 	—	—	—	—	—	—	—	—	—	—	—	—
Poliovirus infection, nonparalytic 	—	—	—	—	—	—	—	—	—	—	—	—
Psittacosis 	S	S	S	S	S	S	S	S	S	S	12	12
Q fever, Total 	1	0.02	3	0.01	7	0.02	99	0.04	10	44	—	164
Q fever, Acute 	1	0.02	2	0.01	6	0.01	83	0.03	8	32	—	132
Q fever, Chronic 	—	—	1	0.00	1	0.00	16	0.01	2	12	—	32
Rabies, Human 	—	—	—	—	—	—	—	—	—	—	—	—
Rubella 	S	S	S	S	S	S	S	S	S	S	1	1
Rubella, congenital syndrome 	S	S	S	S	S	S	S	S	S	S	2	2
Salmonellosis 	532	11.49	1,671	8.16	4,401	9.71	34,546	13.67	2,456	10,244	—	53,850
Severe acute respiratory syndrome-associated coronavirus disease 	—	—	—	—	—	—	—	—	—	—	—	—
Shiga toxin-producing Escherichia coli ††	58	1.25	174	0.85	341	0.75	5,563	2.20	361	1,672	—	8,169
Shigellosis 	320	6.91	328	1.60	3,982	8.79	11,547	4.57	1,039	3,881	—	21,097
Smallpox 	—	—	—	—	—	—	—	—	—	—	—	—
Spotted fever rickettsiosis, Total 	42	0.93	16	0.08	112	0.25	2,927	1.16	62	1,110	—	4,269
Spotted fever rickettsiosis, Confirmed 	3	0.07	—	—	8	0.02	98	0.04	4	41	—	154
Spotted fever rickettsiosis, Probable 	39	0.87	16	0.08	104	0.23	2,829	1.12	58	1,069	—	4,115
Streptococcal toxic shock syndrome 	1	0.04	6	0.06	43	0.14	194	0.12	14	25	—	283
Syphilis, Total, all stages †,§§	613	13.24	2,353	11.49	30,820	68.02	41,719	16.51	6,062	6,475	—	88,042
Syphilis, Congenital 	12	15.49	26	10.39	261	38.32	281	9.49	14	34	—	628
Syphilis, Primary and secondary †	219	4.73	768	3.75	9,341	20.62	14,103	5.58	1,673	1,710	—	27,814
Tetanus 	—	—	1	0.00	3	0.01	21	0.01	2	7	—	34
Toxic shock syndrome (other than Streptococcal) 	—	—	1	0.01	1	0.00	25	0.01	2	11	—	40
Trichinellosis 	5	0.11	8	0.04	2	0.00	8	0.00	—	3	—	26
Tuberculosis 	127	2.74	3,212	15.68	2,026	4.47	3,676	1.45	132	99	—	9,272
Tularemia 	23	0.50	—	—	5	0.01	152	0.06	7	43	—	230
Typhoid fever 	4	0.09	185	0.90	31	0.07	61	0.02	29	66	—	376
Vancomycin-intermediate Staphylococcus aureus 	1	0.03	2	0.02	23	0.06	61	0.03	6	15	—	108
Vancomycin-resistant Staphylococcus aureus 	—	—	—	—	—	—	—	—	—	—	—	—
Varicella morbidity 	84	2.40	404	2.31	556	1.51	5,583	2.77	375	1,951	—	8,953
Varicella mortality 	U	U	U	U	U	U	U	U	U	U	U	U
Vibriosis, Total 	9	0.20	45	0.22	76	0.17	856	0.34	36	251	—	1,273
Vibriosis, Confirmed 	9	0.20	42	0.21	71	0.16	837	0.34	36	246	—	1,241
Vibriosis, Probable 	—	—	3	0.01	5	0.01	19	0.01	—	5	—	32
Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Ebola virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Guanarito virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Junin virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Lassa virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Lujo virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Machupo virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Marburg virus 	—	—	—	—	—	—	—	—	—	—	—	—
Viral hemorrhagic fevers, Sabia virus 	—	—	—	—	—	—	—	—	—	—	—	—
Yellow fever 	S	S	S	S	S	S	S	S	S	S	1	1
Zika virus, Zika virus disease, congenital ¶¶	—	—	—	—	3	0.44	5	0.17	6	16	—	30
Zika virus, Zika virus disease, non-congenital 	7	0.15	77	0.38	432	0.95	2,516	1.00	492	1,608	—	5,132
Zika virus, Zika virus infection, congenital ¶¶	—	—	—	—	1	0.15	4	0.14	8	32	—	45
Zika virus, Zika virus infection, non-congenital 	—	—	27	0.13	218	0.48	240	0.09	120	306	—	911

—: No reported cases
U: Unavailable
S: Suppressed

* Condition had <25 cases reported in the year so data were not broken down by race. 

† Race data were collected using current Office of Management and Budget (OMB) standards for race/ethnicity data and were mapped to bridged race categories.

§ Reportable in <25 states.

¶ Total number of reported laboratory-positive dengue cases, including all confirmed cases [by anti-dengue virus (DENV) molecular diagnostic methods or seroconversion of anti-DENV IgM] and all probable cases (by a single, positive anti-DENV IgM).

** Chronic hepatitis B and C data are not included in NNDSS tables but reported case counts are included in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm.

†† Includes Escherichia coli O157:H7; shiga toxin-positive, serogroup non-O157; and shiga toxin positive, not serogrouped.

§§ Includes syphilis of all stages, including cases where stage of syphilis is not stated.

¶¶ Data reported to ArboNET using the national surveillance case definition for congenital Zika virus disease or infection (CSTE Position Statement 16-ID-01).  Additional data reported to the US Zika Pregnancy Registry for outcomes of pregnancies with laboratory evidence of possible Zika virus infection are available at https://www.cdc.gov/zika/reporting/pregnancy-outcomes.html.  Cases reported to the US Zika Pregnancy Registry might not meet the national surveillance case definition for congenital Zika virus disease or infection.


Notes:

	These are annual cases of selected infectious 
	national notifiable diseases from the 
	National Notifiable Diseases Surveillance System (NNDSS).  
	NNDSS data reported by the 50 states, New York City, the District of Columbia, 
	and the U.S. territories are collated and published. 
	Cases are reported by state health departments to CDC weekly.  
	Annual data may differ from previously reported  weekly and quarterly data 
	due to revision of information and delayed reporting. 

	The list of national notifiable infectious diseases and conditions for 2016 and their national 
	surveillance case definitions are available at 
	https://wwwn.cdc.gov/nndss/conditions/notifiable/2016/infectious-diseases/, https://wwwn.cdc.gov/nndss/conditions/notifiable/2016/infectious-diseases/.   
	This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position 
	statements approved in 2015 by CSTE for national surveillance, that were implemented in 
	January 2016, including updated surveillance case definitions for acute hepatitis C and chronic 
	hepatitis C virus infections.  2016 data are reported through June 30, 2017.  
	Publication criteria for the finalized 2016 data are available at https://wonder.cdc.gov/nndss/documents/2016_NNDSS_Publication_Criteria.pdf, /nndss/documents/2016_NNDSS_Publication_Criteria.pdf.
	See also https://wwwn.cdc.gov/nndss/document/guide_to_interpreting_provisional_and_finalized_nndss_data_tables.pdf, 
	Guide to Interpreting Provisional and Finalized NNDSS Data. 


	Population estimates for incidence rates are July 1st, 2016 estimates
	obtained from the National Center for Health Statistics (NCHS) 
	postcensal estimates of the resident population of the United States for July 1, 2011 - July 1, 2016, 
	by year, county, single year of age (range: 0 to 85 years), bridged-race 
	(white, black or African American, American Indian or Alaska Native, Asian, or Pacific Islander), 
	Hispanic ethnicity (not Hispanic or Latino, Hispanic or Latino),  and sex 
	(Vintage 2016), prepared under a collaborative arrangement with the U.S. Census Bureau.
	Population estimates for states as of June 26, 2017 are available at 
	 https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm, https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm.  
	 Population estimates for territories are the 2016 mid-year estimates from the U.S. Census Bureau 
	 International Data Base accessed on July 24, 2017 at 
	 https://www.census.gov/population/international/data/idb/informationGateway.php, https://www.census.gov/population/international/data/idb/informationGateway.php. 
	 The choice of population denominators for incidence is based on the availability of population 
	 data at the time of publication preparation.  

	NNDSS data displayed in the annual tables are accurate as of October 17, 2017; source data may be updated as additional information is received.

	Annual tables for 2016 are available on https://wonder.cdc.gov/nndss/nndss_annual_tables_menu.asp, CDC WONDER.

	Annual summary reports from 1993-2015 are available as published in the 
	https://www.cdc.gov/mmwr/mmwr_nd/index.html, MMWR.

	Annual summary reports from 1952-1992 are available as published in the MMWR in the 
	
	https://stacks.cdc.gov/, CDC Stacks. 
	


https://wwwn.cdc.gov/nndss/, National Notifiable Diseases Surveillance System

Provided by https://wonder.cdc.gov, CDC WONDER